Literature DB >> 1981689

Two distinct alpha 1-adrenoceptor subtypes involved in noradrenaline contraction of the rabbit thoracic aorta.

I Muramatsu1, S Kigoshi, M Oshita.   

Abstract

1. Recently, alpha 1-adrenoceptors in blood vessels have been classified into three subtypes (alpha 1H, alpha 1L and alpha 1N). We examined which subtype (or subtypes) is involved in the noradrenaline-induced contraction of rabbit thoracic aorta. 2. Noradrenaline produced a concentration-dependent contraction in the rabbit isolated thoracic aorta. Prazosin antagonized the contractions to noradrenaline, resulting in a rightward displacement of the concentration-response curve. However, the shift was not proportional to the concentration of prazosin; Schild plots showed that the inhibition by prazosin was biphasic, implying that noradrenaline acted through two receptor populations. Two affinity constants (pKB values of 10.02 and 8.83) were determined for prazosin at these sites. 3. However, under continuous treatment with 1 nM prazosin, or in strips pretreated with chlorethylclonidine (CEC; an alpha 1H inactivating agent) to remove the contribution of one receptor population, prazosin showed a single pKB or pA2 value of approximately 8.3. 4. Yohimbine also produced biphasic antagonism of noradrenaline-induced contractions, resulting in two affinity constants (pKB = 6.52 and 6.17). However, a monophasic Schild plot was obtained for yohimbine either in the presence of 1 nM prazosin (pA2 = 6.08) or in strips pretreated with CEC (pA2 = 6.03). 5. The Schild plot for HV723 (a selective alpha 1N-antagonist) yielded a monophasic slope (pKB = 8.47) and the inhibition was not affected by 1 nM prazosin or CEC-pretreatment. 6. [3H]-prazosin bound to alpha 1-adrenoceptors of the aortic membrane preparations with two different affinities (pKD = 9.94 and 8.37). The high but not the low affinity site was completely masked by 1 nM prazosin and inactivated by pretreatment with CEC. 7. These results strongly suggest that noradrenaline-induced contraction of the rabbit thoracic aorta is mediated through two distinct alpha l-adrenoceptor subtypes, designated alpha 1H and (alpha lL*

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981689      PMCID: PMC1917726          DOI: 10.1111/j.1476-5381.1990.tb14137.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

Review 1.  Catecholamine action on smooth muscle.

Authors:  E Bülbring; T Tomita
Journal:  Pharmacol Rev       Date:  1987-03       Impact factor: 25.468

2.  Limitations of Schild plots in a two-receptor system: alpha adrenoceptors of vascular smooth muscle.

Authors:  W R Milnor
Journal:  J Pharmacol Exp Ther       Date:  1986-07       Impact factor: 4.030

Review 3.  The classification of drugs and drug receptors in isolated tissues.

Authors:  T P Kenakin
Journal:  Pharmacol Rev       Date:  1984-09       Impact factor: 25.468

4.  Differential interactions of clonidine and methoxamine with the postsynaptic alpha-adrenoceptor of rabbit main pulmonary artery.

Authors:  M I Holck; C H Jones; G Haeusler
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

5.  Ligand: a versatile computerized approach for characterization of ligand-binding systems.

Authors:  P J Munson; D Rodbard
Journal:  Anal Biochem       Date:  1980-09-01       Impact factor: 3.365

6.  The effect of reserpine on sympathetic, purinergic neurotransmission in the isolated mesenteric artery of the dog: a pharmacological study.

Authors:  I Muramatsu
Journal:  Br J Pharmacol       Date:  1987-07       Impact factor: 8.739

7.  Heterogeneity of alpha 1 receptors associated with vascular smooth muscle: evidence from functional and ligand binding studies.

Authors:  M Babich; N W Pedigo; B T Butler; M T Piascik
Journal:  Life Sci       Date:  1987-08-10       Impact factor: 5.037

8.  Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding.

Authors:  A L Morrow; I Creese
Journal:  Mol Pharmacol       Date:  1986-04       Impact factor: 4.436

9.  Some quantitative uses of drug antagonists.

Authors:  O ARUNLAKSHANA; H O SCHILD
Journal:  Br J Pharmacol Chemother       Date:  1959-03

10.  Alpha adrenergic receptor subtype associated with receptor binding, Ca++ influx, Ca++ release and contractile events in the rabbit aorta.

Authors:  R Awad; R Payne; R C Deth
Journal:  J Pharmacol Exp Ther       Date:  1983-10       Impact factor: 4.030

View more
  15 in total

1.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

2.  Pharmacokinetic and alpha 1-adrenoceptor antagonistic properties of two cyanine-type inhibitors of extraneuronal monoamine transport.

Authors:  H Russ; B Friedgen; B Königs; C Schumacher; K H Graefe; E Schömig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996 Aug-Sep       Impact factor: 3.000

3.  Three distinct binding sites for [3H]-prazosin in the rat cerebral cortex.

Authors:  M Oshita; S Kigoshi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

4.  Two distinct alpha 1-adrenoceptor subtypes in rabbit liver: a binding study.

Authors:  T Ohmura; I Muramatsu
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

5.  Actions of alpha-adrenoceptor blocking agents on two types of intracellular calcium stores mobilized by noradrenaline in rat aorta.

Authors:  M A Noguera; S Calatayud; M P D'Ocon
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

6.  Relation between alpha 1-adrenoceptor subtypes and noradrenaline-induced contraction in rat portal vein smooth muscle.

Authors:  I Sayet; G Neuilly; L Rakotoarisoa; C Mironneau; J Mironneau
Journal:  Br J Pharmacol       Date:  1993-09       Impact factor: 8.739

7.  Pharmacological characterization of two distinct alpha 1-adrenoceptor subtypes in rabbit thoracic aorta.

Authors:  M Oshita; S Kigoshi; I Muramatsu
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  Pharmacological profiles of a novel alpha 1-adrenoceptor agonist, PNO-49B, at alpha 1-adrenoceptor subtypes.

Authors:  I Muramatsu; T Ohmura; S Kigoshi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-01       Impact factor: 3.000

9.  Characterization of the alpha1-adrenoceptor subtype mediating contractions of the pig internal anal sphincter.

Authors:  Ka Mills; N Hausman; R Chess-Williams
Journal:  Br J Pharmacol       Date:  2008-06-02       Impact factor: 8.739

10.  Pharmacological properties of the cloned alpha 1A/D-adrenoceptor subtype are consistent with the alpha 1A-adrenoceptor characterized in rat cerebral cortex and vas deferens.

Authors:  B A Kenny; A M Naylor; P M Greengrass; M J Russell; S J Friend; A M Read; M G Wyllie
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.